Mouse colon cancer cells (CT26. WT)

The Mouse colon cancer cells (CT26WT) offer a valuable resource for preclinical cancer research by providing a robust model for studying tumor biology and testing therapeutic strategies in vitro When preserved in dry ice or transported as live cell cultures these fibroblast-like adherent growth cells maintain viability and functionality allowing researchers to conduct experiments with a focus on cancer progression metastasis and response to treatment regimens

In drug discovery CT26WT cells are instrumental for screening potential anti-cancer compounds enabling researchers to evaluate the efficacy of various treatments in modulating cell proliferation and survival By using RPMI-1640 supplemented with 10% FBS normalized culture conditions promote optimal growth and experimental consistency thereby enhancing the reliability of findings related to colon cancer therapeutics

Moreover the negative growth factor response of these cells allows for investigating the mechanisms of resistance to therapies leading to the identification of new targets for intervention This versatility makes CT26WT cells an indispensable tool in cancer research facilitating advancements in the understanding and treatment of colon cancer